Highlights from the SWG

ELN Management Recommendations for CML:
Ongoing

Meeting activities for promotion of cooperative research in the field of CML

EUTOS (European treatment and outcome study):
2016-2018
2019-2022

Private-public partnership with Novartis:
12 participants in 7 European countries.

The overall objectives of this CML collaboration are:

  • Promote quality controlled molecular monitoring and mutational analyses using standardized RQ-PCR technologies, including definition and validation of an international definition of molecular response, and further expand the validation of laboratory measuring BCR-ABL according to International Scale
  • Establish new methods to evaluate molecular response on the stem cell level
  • Enhance the cooperation among European scientists to provide a platform for the expedited evaluation of new treatments, combination and discontinuation strategies with the objective of progressing towards curing CML.